HELP PREVENT A SECOND CV EVENT
WITH BAYER® ASPIRIN
After one MI or stroke,* your patients' risk for a second increases1,2
Recommend Safety Coated Bayer® Aspirin today to decrease their risk.3
Download patient education and support materials, treatment guidelines, and select publications
91% of patients with cardiovascular disease adhere to an aspirin regimen for secondary CV prevention when instructed to by their doctor4
Help prevent another CV event. Recommend Bayer® Aspirin.
*Nonfatal myocardial infarction or ischemic stroke.
References: 1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update. A report from the American Heart Association. Circulation. 2019;139:e56-e528. doi:10.1161/CIR.0000000000000659 2. American Stroke Association website. https//www.stroke.org/en/life-after-stroke/preventing-another-stroke. Accessed June 3, 2021. 3. Antithrombotic Trialists’ (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849-1860. 4. Gu Q, Dillon CF, Eberhardt MS, Wright JD, Burt VL. Preventive aspirin and other antiplatelet medication use among U.S. adults aged ≥40 years: data from the national health and nutrition examination survey, 2011-2012. Public Health Rep. 2015;130(6):643-654.